{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:45:09Z","timestamp":1757616309920,"version":"3.44.0"},"publisher-location":"Cham","reference-count":107,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031459559"},{"type":"electronic","value":"9783031459566"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-45956-6_15","type":"book-chapter","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T17:02:20Z","timestamp":1704301340000},"page":"377-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Smart Targeted-Nanocarriers for Cancer Therapeutics"],"prefix":"10.1007","author":[{"given":"D\u00e9bora","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Figueiredo","sequence":"additional","affiliation":[]},{"given":"Ligia","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11095-020-02938-1","volume":"37","author":"AAH Abdellatif","year":"2020","unstructured":"Abdellatif AAH, Hennig R, Pollinger K, Tawfeek HM, Bouazzaoui A, Goepferich A (2020) Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment. Pharm Res 37:217. https:\/\/doi.org\/10.1007\/s11095-020-02938-1","journal-title":"Pharm Res"},{"key":"15_CR2","unstructured":"Abdellatif AA, Abdelhafez WA, Sarhan HA (2018) Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors., Iran. J. Pharm. Res. IJPR. 17 (2018) 513\u2013524. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29881409"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1568009622666220120115140","volume":"22","author":"N Alavi","year":"2022","unstructured":"Alavi N, Rezaei M, Maghami P, Fanipakdel A, Avan A (2022) Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin. Curr Cancer Drug Targets 22:361\u2013372. https:\/\/doi.org\/10.2174\/1568009622666220120115140","journal-title":"Curr Cancer Drug Targets"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/439389","volume":"2009","author":"M Arruebo","year":"2009","unstructured":"Arruebo M, Valladares M, Gonz\u00e1lez-Fern\u00e1ndez \u00c1 (2009) Antibody-Conjugated Nanoparticles for Biomedical Applications. J Nanomater 2009:1\u201324. https:\/\/doi.org\/10.1155\/2009\/439389","journal-title":"J Nanomater"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","volume":"4","author":"KA Autio","year":"2018","unstructured":"Autio KA, Dreicer R, Anderson J, Garcia JA, Alva A, Hart LL, Milowsky MI, Posadas EM, Ryan CJ, Graf RP, Dittamore R, Schreiber NA, Summa JM, Youssoufian H, Morris MJ, Scher HI (2018) Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Oncol 4:1344. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2168","journal-title":"JAMA Oncol"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.smim.2017.10.001","volume":"34","author":"F Barbero","year":"2017","unstructured":"Barbero F, Russo L, Vitali M, Piella J, Salvo I, Borrajo ML, Busquets-Fit\u00e9 M, Grandori R, Bast\u00fas NG, Casals E, Puntes V (2017) Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System. Semin Immunol 34:52\u201360. https:\/\/doi.org\/10.1016\/j.smim.2017.10.001","journal-title":"Semin Immunol"},{"key":"15_CR7","doi-asserted-by":"publisher","unstructured":"Brandsma D, Kerklaan BM, Di\u00e9ras V, Altintas S, Anders CK, Ballester MA, Gelderblom H, Soetekouw PM, Gladdines W, Lonnqvist F, Jager A (2014) Phase 1\/2A Study of Glutathione Pegylated Liposomal Doxorubicin (2B3\u2013101) in Patients with Brain Metastases (Bm) from Solid Tumors or Recurrent High Grade Gliomas (Hgg), Ann. Oncol. 25 (2014) iv157. https:\/\/doi.org\/10.1093\/annonc\/mdu331.32.","DOI":"10.1093\/annonc\/mdu331.32"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1021\/nl1002526","volume":"10","author":"FM Brunel","year":"2010","unstructured":"Brunel FM, Lewis JD, Destito G, Steinmetz NF, Manchester M, Stuhlmann H, Dawson PE (2010) Hydrazone Ligation Strategy to Assemble Multifunctional Viral Nanoparticles for Cell Imaging and Tumor Targeting. Nano Lett 10:1093\u20131097. https:\/\/doi.org\/10.1021\/nl1002526","journal-title":"Nano Lett"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/life11030193","volume":"11","author":"J Byun","year":"2021","unstructured":"Byun J (2021) Recent Progress and Opportunities for Nucleic Acid Aptamers. Life 11:193. https:\/\/doi.org\/10.3390\/life11030193","journal-title":"Life"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/ijms20010204","volume":"20","author":"G Cappellano","year":"2019","unstructured":"Cappellano G, Comi C, Chiocchetti A, Dianzani U (2019) Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease. Int J Mol Sci 20:204. https:\/\/doi.org\/10.3390\/ijms20010204","journal-title":"Int J Mol Sci"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3390\/biophysica2030021","volume":"2","author":"J Cathcart","year":"2022","unstructured":"Cathcart J, Suarato G, Li W, Cao J, Meng Y (2022) Peptide-Functionalized Nanoparticles for the Targeted Delivery of Cytotoxins to MMP-14-Expressing Cancer Cells. Biophysica 2:203\u2013220. https:\/\/doi.org\/10.3390\/biophysica2030021","journal-title":"Biophysica"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.omto.2018.12.005","volume":"12","author":"SP Chawla","year":"2019","unstructured":"Chawla SP, Bruckner H, Morse MA, Assudani N, Hall FL, Gordon EM (2019) A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer. Mol. Ther.  Oncolytics. 12:56\u201367. https:\/\/doi.org\/10.1016\/j.omto.2018.12.005","journal-title":"Mol. Ther. - Oncolytics."},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/mt.2009.126","volume":"17","author":"SP Chawla","year":"2009","unstructured":"Chawla SP, Chua VS, Fernandez L, Quon D, Saralou A, Blackwelder WC, Hall FL, Gordon EM (2009) Phase I\/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma. Mol Ther 17:1651\u20131657. https:\/\/doi.org\/10.1038\/mt.2009.126","journal-title":"Mol Ther"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.talanta.2017.09.043","volume":"178","author":"Z Chen","year":"2018","unstructured":"Chen Z, Sun M, Luo F, Xu K, Lin Z, Zhang L (2018) Stimulus-response click chemistry based aptamer-functionalized mesoporous silica nanoparticles for fluorescence detection of thrombin. Talanta 178:563\u2013568. https:\/\/doi.org\/10.1016\/j.talanta.2017.09.043","journal-title":"Talanta"},{"key":"15_CR15","doi-asserted-by":"publisher","unstructured":"Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities., Science. 338 (2012) 903\u201310. https:\/\/doi.org\/10.1126\/science.1226338","DOI":"10.1126\/science.1226338"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ijpharm.2017.03.007","volume":"532","author":"J Choi","year":"2017","unstructured":"Choi J, Rustique E, Henry M, Guidetti M, Josserand V, Sancey L, Boutet J, Coll J-L (2017) Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation. Int J Pharm 532:677\u2013685. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.007","journal-title":"Int J Pharm"},{"key":"15_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102089","volume":"23","author":"H-J Chung","year":"2020","unstructured":"Chung H-J, Kim H-J, Hong S-T (2020) Tumor-specific delivery of a paclitaxel-loading HSA-haemin nanoparticle for cancer treatment, Nanomedicine Nanotechnology. Biol Med 23:102089. https:\/\/doi.org\/10.1016\/j.nano.2019.102089","journal-title":"Biol Med"},{"key":"15_CR18","doi-asserted-by":"publisher","unstructured":"Comparetti EJ, Romagnoli GG, Gorgulho CM, de Albuquerque Pedrosa V, Kaneno R (2020) Anti-PSMA monoclonal antibody increases the toxicity of paclitaxel carried by carbon nanotubes, Mater. Sci. Eng. C. 116 (2020) 111254. https:\/\/doi.org\/10.1016\/j.msec.2020.111254","DOI":"10.1016\/j.msec.2020.111254"},{"key":"15_CR19","doi-asserted-by":"publisher","unstructured":"Cypriyana J, Angalene LA, Samrot AV, Kumar S, Ponniah P, Chakravarthi S (2021) Overview on toxicity of nanoparticles, it\u2019s mechanism, models used in toxicity studies and disposal methods \u2013 a review, Biocatal. Agric Biotechnol 36 (2021) 102117. https:\/\/doi.org\/10.1016\/j.bcab.2021.102117.","DOI":"10.1016\/j.bcab.2021.102117"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2147\/IJN.S153795","volume":"13","author":"D Duan","year":"2018","unstructured":"Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y (2018) Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo. Int J Nanomedicine 13:1831\u20131840. https:\/\/doi.org\/10.2147\/IJN.S153795","journal-title":"Int J Nanomedicine"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"AD Ellington","year":"1990","unstructured":"Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818\u2013822. https:\/\/doi.org\/10.1038\/346818a0","journal-title":"Nature"},{"key":"15_CR22","doi-asserted-by":"publisher","unstructured":"Ernstoff MS, Ma WW, Tsai FY, Munster PN, Zhang T, Kamoun W, Pipas JM, Chen S, Santillana S, Askoxylakis V (2018) A phase 1 study evaluating the safety, pharmacology and preliminary activity of MM-310 in patients with solid tumors., J. Clin. Oncol. 36 (2018) TPS2604\u2013TPS2604. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.TPS2604","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS2604"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","volume":"64","author":"OC Farokhzad","year":"2004","unstructured":"Farokhzad OC, Jon S, Khademhosseini A, Tran T-NT, LaVan DA, Langer R (2004) Nanoparticle-Aptamer Bioconjugates. Cancer Res 64:7668\u20137672. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2550","journal-title":"Cancer Res"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1038\/s41598-021-87998-y","volume":"11","author":"D Ferreira","year":"2021","unstructured":"Ferreira D, Barbosa J, Sousa DA, Silva C, Melo LDR, Avci-Adali M, Wendel HP, Rodrigues LR (2021) Selection of aptamers against triple negative breast cancer cells using high throughput sequencing. Sci Rep 11:8614. https:\/\/doi.org\/10.1038\/s41598-021-87998-y","journal-title":"Sci Rep"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41598-019-40562-1","volume":"9","author":"D Ferreira","year":"2019","unstructured":"Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, Martins SF, Baltazar F, Rodrigues LR (2019) Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display. Sci Rep 9:3958. https:\/\/doi.org\/10.1038\/s41598-019-40562-1","journal-title":"Sci Rep"},{"key":"15_CR26","doi-asserted-by":"publisher","unstructured":"Ferreira D, Martins IM (2017) Artificial virus particles, in: Bioinspired Mater. Med. Appl., Elsevier, 2017: pp. 427\u2013450. https:\/\/doi.org\/10.1016\/B978-0-08-100741-9.00015-2","DOI":"10.1016\/B978-0-08-100741-9.00015-2"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.2174\/13816128113199990375","volume":"19","author":"AD Friedman","year":"2013","unstructured":"Friedman AD, Claypool SE, Liu R (2013) The smart targeting of nanoparticles. Curr Pharm Des 19:6315\u20136329","journal-title":"Curr Pharm Des"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/ijms21082793","volume":"21","author":"Z Fu","year":"2020","unstructured":"Fu Z, Xiang J (2020) Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Int J Mol Sci 21:2793. https:\/\/doi.org\/10.3390\/ijms21082793","journal-title":"Int J Mol Sci"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.2147\/IJN.S134148","volume":"12","author":"F Gao","year":"2017","unstructured":"Gao F, Zhang J, Fu C, Xie X, Peng F, You J, Tang H, Wang Z, Li P, Chen J (2017) iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability. Int J Nanomedicine 12:4147\u20134162. https:\/\/doi.org\/10.2147\/IJN.S134148","journal-title":"Int J Nanomedicine"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijpharm.2014.11.029","volume":"478","author":"H Gao","year":"2015","unstructured":"Gao H, Zhang Q, Yang Y, Jiang X, He Q (2015) Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy. Int J Pharm 478:240\u2013250. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.11.029","journal-title":"Int J Pharm"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00262-018-2207-z","volume":"67","author":"T Gargett","year":"2018","unstructured":"Gargett T, Abbas MN, Rolan P, Price JD, Gosling KM, Ferrante A, Ruszkiewicz A, Atmosukarto IIC, Altin J, Parish CR, Brown MP (2018) Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma. Cancer Immunol Immunother 67:1461\u20131472. https:\/\/doi.org\/10.1007\/s00262-018-2207-z","journal-title":"Cancer Immunol Immunother"},{"key":"15_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111673","volume":"202","author":"Z Gong","year":"2021","unstructured":"Gong Z, Liu X, Zhou B, Wang G, Guan X, Xu Y, Zhang J, Hong Z, Cao J, Sun X, Gao Z, Lu H, Pan X, Bai J (2021) Tumor acidic microenvironment-induced drug release of RGD peptide nanoparticles for cellular uptake and cancer therapy. Colloids Surfaces B Biointerfaces. 202:111673. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111673","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"15_CR33","doi-asserted-by":"crossref","unstructured":"Gordon EM, Lopez FF, Cornelio GH, Lorenzo CC, Levy JP, Reed RA, Liu L, Bruckner HW, Hall FL (2006)  Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience., Int. J. Oncol. 29 :1053\u201364","DOI":"10.3892\/ijo.29.5.1053"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11373-006-9121-7","volume":"14","author":"R Huang","year":"2007","unstructured":"Huang R, Ke W, Qu Y, Zhu J, Pei Y, Jiang C (2007) Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. J Biomed Sci 14:121\u2013128. https:\/\/doi.org\/10.1007\/s11373-006-9121-7","journal-title":"J Biomed Sci"},{"key":"15_CR35","doi-asserted-by":"publisher","unstructured":"Jalilian M, Derakhshandeh K, Kurd M, Lashani H (2021) Targeting Solid Lipid Nanoparticles with Anisamide for Docetaxel Delivery to Prostate Cancer: Preparation, Optimization, and In-vitro Evaluation., Iran. J. Pharm. Res. IJPR. 20 327\u2013338. https:\/\/doi.org\/10.22037\/ijpr.2020.113436.14302.","DOI":"10.22037\/ijpr.2020.113436.14302"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1021\/bc8001248","volume":"19","author":"DJ Javier","year":"2008","unstructured":"Javier DJ, Nitin N, Levy M, Ellington A, Richards-Kortum R (2008) Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging. Bioconjug Chem 19:1309\u20131312. https:\/\/doi.org\/10.1021\/bc8001248","journal-title":"Bioconjug Chem"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3762\/bjnano.9.98","volume":"9","author":"J Jeevanandam","year":"2018","unstructured":"Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK (2018) Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol 9:1050\u20131074. https:\/\/doi.org\/10.3762\/bjnano.9.98","journal-title":"Beilstein J Nanotechnol"},{"key":"15_CR38","doi-asserted-by":"publisher","unstructured":"Jia Y, Chen S, Wang C, Sun T, Yang L (2022) Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances, Front. Bioeng. Biotechnol. 10 (2022). https:\/\/doi.org\/10.3389\/fbioe.2022.990145.","DOI":"10.3389\/fbioe.2022.990145"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1039\/C8BM01340C","volume":"7","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Guan J, Qian J, Zhan C (2019) Peptide ligand-mediated targeted drug delivery of nanomedicines. Biomater Sci 7:461\u2013471. https:\/\/doi.org\/10.1039\/C8BM01340C","journal-title":"Biomater Sci"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1021\/bc3004815","volume":"24","author":"PP Joshi","year":"2013","unstructured":"Joshi PP, Yoon SJ, Hardin WG, Emelianov S, Sokolov KV (2013) Conjugation of Antibodies to Gold Nanorods through Fc Portion: Synthesis and Molecular Specific Imaging. Bioconjug Chem 24:878\u2013888. https:\/\/doi.org\/10.1021\/bc3004815","journal-title":"Bioconjug Chem"},{"key":"15_CR41","doi-asserted-by":"publisher","unstructured":"Kapoor D, Bhatt S, Kumar M, Maheshwari R, Tekade RK (2019) Ligands for Targeted Drug Delivery and Applications, in: Basic Fundam. Drug Deliv., Elsevier, pp. 307\u2013342. https:\/\/doi.org\/10.1016\/B978-0-12-817909-3.00008-X","DOI":"10.1016\/B978-0-12-817909-3.00008-X"},{"key":"15_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100365","volume":"7","author":"B Kasenda","year":"2022","unstructured":"Kasenda B, K\u00f6nig D, Manni M, Ritschard R, Duthaler U, Bartoszek E, B\u00e4renwaldt A, Deuster S, Hutter G, Cordier D, Mariani L, Hench J, Frank S, Kr\u00e4henb\u00fchl S, Zippelius A, Rochlitz C, Mamot C, Wicki A, L\u00e4ubli H (2022) Targeting immunoliposomes to EGFR-positive glioblastoma. ESMO Open. 7:100365. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100365","journal-title":"ESMO Open."},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40005-020-00504-w","volume":"51","author":"TM Kiio","year":"2021","unstructured":"Kiio TM, Park S (2021) Physical properties of nanoparticles do matter. J Pharm Investig 51:35\u201351. https:\/\/doi.org\/10.1007\/s40005-020-00504-w","journal-title":"J Pharm Investig"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2011.10.032","volume":"158","author":"E Kluza","year":"2012","unstructured":"Kluza E, Jacobs I, Hectors SJCG, Mayo KH, Griffioen AW, Strijkers GJ, Nicolay K (2012) Dual-targeting of \u03b1v\u03b23 and galectin-1 improves the specificity of paramagnetic\/fluorescent liposomes to tumor endothelium in vivo. J Control Release 158:207\u2013214. https:\/\/doi.org\/10.1016\/j.jconrel.2011.10.032","journal-title":"J Control Release"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.biomaterials.2010.10.034","volume":"32","author":"HY Ko","year":"2011","unstructured":"Ko HY, Choi K-J, Lee CH, Kim S (2011) A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin \u03b1v\u03b23 and tenascin-C proteins. Biomaterials 32:1130\u20131138. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.10.034","journal-title":"Biomaterials"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/acs.molpharmaceut.6b00051","volume":"13","author":"Y Kuang","year":"2016","unstructured":"Kuang Y, Jiang X, Zhang Y, Lu Y, Ma H, Guo Y, Zhang Y, An S, Li J, Liu L, Wu Y, Liang J, Jiang C (2016) Dual Functional Peptide-Driven Nanoparticles for Highly Efficient Glioma-Targeting and Drug Codelivery. Mol Pharm 13:1599\u20131607. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00051","journal-title":"Mol Pharm"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nprot.2008.1","volume":"3","author":"S Kumar","year":"2008","unstructured":"Kumar S, Aaron J, Sokolov K (2008) Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat Protoc 3:314\u2013320. https:\/\/doi.org\/10.1038\/nprot.2008.1","journal-title":"Nat Protoc"},{"key":"15_CR48","doi-asserted-by":"publisher","unstructured":"Leach JC, Wang A, Ye K, Jin S (2016) A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery. Int. J. Mol. Sci. 17 (2016) 380. https:\/\/doi.org\/10.3390\/ijms17030380.","DOI":"10.3390\/ijms17030380"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jconrel.2011.05.025","volume":"155","author":"I-H Lee","year":"2011","unstructured":"Lee I-H, An S, Yu MK, Kwon H-K, Im S-H, Jon S (2011) Targeted chemoimmunotherapy using drug-loaded aptamer\u2013dendrimer bioconjugates. J Control Release 155:435\u2013441. https:\/\/doi.org\/10.1016\/j.jconrel.2011.05.025","journal-title":"J Control Release"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/288602a0","volume":"288","author":"LD Leserman","year":"1980","unstructured":"Leserman LD, Barbet J, Kourilsky F, Weinstein JN (1980) Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A. Nature 288:602\u2013604. https:\/\/doi.org\/10.1038\/288602a0","journal-title":"Nature"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1200\/JCO.2021.39.15_suppl.4139","volume":"39","author":"CP Leung","year":"2021","unstructured":"Leung CP, Barve MA, Wu M-S, Pirollo KF, Strauss JF, Liao W-C, Yang S-H, Nunan RA, Adams J, Harford JB, Chang EH (2021) A phase II trial combining tumor-targeting TP53 gene therapy with gemcitabine\/nab-paclitaxel as a second-line treatment for metastatic pancreatic cancer. J Clin Oncol 39:4139\u20134139. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_suppl.4139","journal-title":"J Clin Oncol"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijbiomac.2017.08.155","volume":"107","author":"H Li","year":"2018","unstructured":"Li H, Tong Y, Bai L, Ye L, Zhong L, Duan X, Zhu Y (2018) Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma. Int J Biol Macromol 107:204\u2013211. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.08.155","journal-title":"Int J Biol Macromol"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/molecules25081853","volume":"25","author":"H-C Lin","year":"2020","unstructured":"Lin H-C, Hsu K-F, Lai C-L, Wu T-C, Chen H-F, Lai C-H (2020) Mannoside-Modified Branched Gold Nanoparticles for Photothermal Therapy to MDA-MB-231 Cells. Molecules 25:1853. https:\/\/doi.org\/10.3390\/molecules25081853","journal-title":"Molecules"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/ma13020375","volume":"13","author":"RB Liszbinski","year":"2020","unstructured":"Liszbinski RB, Romagnoli GG, Gorgulho CM, Basso CR, Pedrosa VA, Kaneno R (2020) Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells. Materials (basel). 13:375. https:\/\/doi.org\/10.3390\/ma13020375","journal-title":"Materials (basel)."},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1039\/C7SC01447C","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hou W, Sun H, Cui C, Zhang L, Jiang Y, Wu Y, Wang Y, Li J, Sumerlin BS, Liu Q, Tan W (2017) Thiol\u2013ene click chemistry: a biocompatible way for orthogonal bioconjugation of colloidal nanoparticles. Chem Sci 8:6182\u20136187. https:\/\/doi.org\/10.1039\/C7SC01447C","journal-title":"Chem Sci"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biomaterials.2017.01.026","volume":"123","author":"J Logie","year":"2017","unstructured":"Logie J, Ganesh AN, Aman AM, Al-Awar RS, Shoichet MS (2017) Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model. Biomaterials 123:39\u201347. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.01.026","journal-title":"Biomaterials"},{"key":"15_CR57","doi-asserted-by":"publisher","unstructured":"Ma WW, Tolcher AW, Strauss JF, Bekaii-Saab TS, Zhao Y, Perez CA, Hamilton EP, Adams GP, Reddick C, Bayever E (2022) ELU-FR\u03b1-1: A study to evaluate ELU001 in patients with solid tumors that overexpress folate receptor alpha (FR\u03b1)., J. Clin. Oncol. 40 (2022) TPS3158\u2013TPS3158. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.TPS3158","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3158"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1021\/bc800077y","volume":"19","author":"G von Maltzahn","year":"2008","unstructured":"von Maltzahn G, Ren Y, Park J-H, Min D-H, Kotamraju VR, Jayakumar J, Fogal V, Sailor MJ, Ruoslahti E, Bhatia SN (2008) In Vivo Tumor Cell Targeting with \u201cClick\u201d Nanoparticles. Bioconjug Chem 19:1570\u20131578. https:\/\/doi.org\/10.1021\/bc800077y","journal-title":"Bioconjug Chem"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S1470-2045(12)70476-X","volume":"13","author":"C Mamot","year":"2012","unstructured":"Mamot C, Ritschard R, Wicki A, Stehle G, Dieterle T, Bubendorf L, Hilker C, Deuster S, Herrmann R, Rochlitz C (2012) Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. Lancet Oncol 13:1234\u20131241. https:\/\/doi.org\/10.1016\/S1470-2045(12)70476-X","journal-title":"Lancet Oncol"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.2147\/DDDT.S296253","volume":"15","author":"K Mao","year":"2021","unstructured":"Mao K, Zhang W, Yu L, Yu Y, Liu H, Zhang X (2021) Transferrin-Decorated Protein-Lipid Hybrid Nanoparticle Efficiently Delivers Cisplatin and Docetaxel for Targeted Lung Cancer Treatment. Drug Des. Devel. Ther. 15:3475\u20133486. https:\/\/doi.org\/10.2147\/DDDT.S296253","journal-title":"Drug Des. Devel. Ther."},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","volume":"320","author":"AC Marques","year":"2020","unstructured":"Marques AC, Costa PJ, Velho S, Amaral MH (2020) Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. J Control Release 320:180\u2013200. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.035","journal-title":"J Control Release"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/bioengineering9070294","volume":"9","author":"SK Marshall","year":"2022","unstructured":"Marshall SK, Panrak Y, Makchuchit N, Jaroenpakdee P, Saelim B, Taweesap M, Pachana V (2022) Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium\/Iodide-Symporter-Mediated Breast-Cancer Treatment. Bioengineering 9:294. https:\/\/doi.org\/10.3390\/bioengineering9070294","journal-title":"Bioengineering"},{"key":"15_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103193","volume":"70","author":"L Meng","year":"2022","unstructured":"Meng L, Ren J, Liu Z, Zhao Y (2022) Hyaluronic acid-coated shikonin liposomes for the treatment of triple-negative breast cancer via targeting tumor cells and amplification of oxidative stress. J. Drug Deliv. Sci. Technol. 70:103193. https:\/\/doi.org\/10.1016\/j.jddst.2022.103193","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101\u2013124. https:\/\/doi.org\/10.1038\/s41573-020-0090-8","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.2174\/1381612825666190903154847","volume":"25","author":"S Molavipordanjani","year":"2019","unstructured":"Molavipordanjani S, Hosseinimehr SJ (2019) Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents. Curr Pharm Des 25:3917\u20133926. https:\/\/doi.org\/10.2174\/1381612825666190903154847","journal-title":"Curr Pharm Des"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-018-0235-2","volume":"119","author":"P Munster","year":"2018","unstructured":"Munster P, Krop IE, LoRusso P, Ma C, Siegel BA, Shields AF, Moln\u00e1r I, Wickham TJ, Reynolds J, Campbell K, Hendriks BS, Adiwijaya BS, Geretti E, Moyo V, Miller KD (2018) Safety and pharmacokinetics of MM-302, a HER2-targeted antibody\u2013liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study. Br J Cancer 119:1086\u20131093. https:\/\/doi.org\/10.1038\/s41416-018-0235-2","journal-title":"Br J Cancer"},{"key":"15_CR67","doi-asserted-by":"publisher","unstructured":"Nehoff H, Parayath NN, Domanovitch L, Taurin S, Greish K (2014) Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect. Int J Nanomedicine 2539. https:\/\/doi.org\/10.2147\/IJN.S47129","DOI":"10.2147\/IJN.S47129"},{"key":"15_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102316","volume":"61","author":"M Nikzamir","year":"2021","unstructured":"Nikzamir M, Akbarzadeh A, Panahi Y (2021) An overview on nanoparticles used in biomedicine and their cytotoxicity. J. Drug Deliv. Sci. Technol. 61:102316. https:\/\/doi.org\/10.1016\/j.jddst.2020.102316","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12885-016-2937-2","volume":"16","author":"FL Nobrega","year":"2016","unstructured":"Nobrega FL, Ferreira D, Martins IM, Suarez-Diez M, Azeredo J, Kluskens LD, Rodrigues LR (2016) Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies. BMC Cancer 16:881. https:\/\/doi.org\/10.1186\/s12885-016-2937-2","journal-title":"BMC Cancer"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.colsurfb.2016.08.005","volume":"147","author":"AC Okur","year":"2016","unstructured":"Okur AC, Erkoc P, Kizilel S (2016) Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles. Colloids Surfaces B Biointerfaces. 147:191\u2013200. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.08.005","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/IJN.S238206","volume":"15","author":"L Peng","year":"2020","unstructured":"Peng L, Liang Y, Zhong X, Liang Z, Tian Y, Li S, Liang J, Wang R, Zhong Y, Shi Y, Zhang X (2020) Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma. Int J Nanomedicine 15:1363\u20131372. https:\/\/doi.org\/10.2147\/IJN.S238206","journal-title":"Int J Nanomedicine"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/cbdd.13816","volume":"97","author":"AC Pereira","year":"2021","unstructured":"Pereira AC, Ferreira D, Santos-Pereira C, Vieira TF, Sousa SF, Sales G, Rodrigues LR (2021) Selection of a new peptide homing SK-BR-3 breast cancer cells. Chem Biol Drug Des 97:893\u2013903. https:\/\/doi.org\/10.1111\/cbdd.13816","journal-title":"Chem Biol Drug Des"},{"key":"15_CR73","doi-asserted-by":"publisher","DOI":"10.1039\/D2ME00022A","author":"A Pereira","year":"2022","unstructured":"Pereira A, Sousa D, Pina A, Ferreira D, Santos-Pereira C, Melo LD, Sales MGF, Sousa S, Rodrigues LR (2022) Identification of novel aptamers targeting Cathepsin B-overexpressing prostate cancer cells. Mol Syst Des Eng. https:\/\/doi.org\/10.1039\/D2ME00022A","journal-title":"Mol. Syst. Des. Eng."},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.2147\/IJN.S322856","volume":"16","author":"B Ren","year":"2021","unstructured":"Ren B, Cai Z-C, Zhao X-J, Li L-S, Zhao M-X (2021) Evaluation of the Biological Activity of Folic Acid-Modified Paclitaxel-Loaded Gold Nanoparticles. Int J Nanomedicine 16:7023\u20137033. https:\/\/doi.org\/10.2147\/IJN.S322856","journal-title":"Int J Nanomedicine"},{"key":"15_CR75","doi-asserted-by":"publisher","unstructured":"Rodrigues JL, Ferreira D, Rodrigues LR (2017) Synthetic biology strategies towards the development of new bioinspired technologies for medical applications, in: Bioinspired Mater. Med. Appl., Elsevier, 451\u2013497. https:\/\/doi.org\/10.1016\/B978-0-08-100741-9.00016-4.","DOI":"10.1016\/B978-0-08-100741-9.00016-4"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"18920","DOI":"10.1021\/acsami.5b06250","volume":"7","author":"N Rubio","year":"2015","unstructured":"Rubio N, Mei K-C, Klippstein R, Costa PM, Hodgins N, Wang JT-W, Festy F, Abbate V, Hider RC, Chan KLA, Al-Jamal KT (2015) Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene Oxide. ACS Appl Mater Interfaces 7:18920\u201318923. https:\/\/doi.org\/10.1021\/acsami.5b06250","journal-title":"ACS Appl Mater Interfaces"},{"key":"15_CR77","doi-asserted-by":"publisher","unstructured":"Salahpour Anarjan F (2019) Active targeting drug delivery nanocarriers: Ligands, Nano-Structures & Nano-Objects. 19 100370. https:\/\/doi.org\/10.1016\/j.nanoso.2019.100370","DOI":"10.1016\/j.nanoso.2019.100370"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijbiomac.2022.01.075","volume":"202","author":"C Santos-Pereira","year":"2022","unstructured":"Santos-Pereira C, Andr\u00e9s MT, Fierro JF, Rodrigues LR, C\u00f4rte-Real M (2022) A review on lactoferrin as a proton pump inhibitor. Int J Biol Macromol 202:309\u2013317. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.075","journal-title":"Int J Biol Macromol"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/pharmaceutics14051113","volume":"14","author":"TA Seidu","year":"2022","unstructured":"Seidu TA, Kutoka PT, Asante DO, Farooq MA, Alolga RN, Bo W (2022) Functionalization of Nanoparticulate Drug Delivery Systems and Its Influence in Cancer Therapy. Pharmaceutics 14:1113. https:\/\/doi.org\/10.3390\/pharmaceutics14051113","journal-title":"Pharmaceutics"},{"key":"15_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2022.102640","volume":"303","author":"A Selmani","year":"2022","unstructured":"Selmani A, Kova\u010devi\u0107 D, Bohinc K (2022) Nanoparticles: From synthesis to applications and beyond. Adv Colloid Interface Sci 303:102640. https:\/\/doi.org\/10.1016\/j.cis.2022.102640","journal-title":"Adv Colloid Interface Sci"},{"key":"15_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102915","volume":"39","author":"VR Shinde","year":"2022","unstructured":"Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK (2022) Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles. Photodiagnosis Photodyn Ther 39:102915. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.102915","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.3390\/molecules26133955","volume":"26","author":"VO Shipunova","year":"2021","unstructured":"Shipunova VO, Sogomonyan AS, Zelepukin IV, Nikitin MP, Deyev SM (2021) PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death. Molecules 26:3955. https:\/\/doi.org\/10.3390\/molecules26133955","journal-title":"Molecules"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/mt.2016.118","volume":"24","author":"A Siefker-Radtke","year":"2016","unstructured":"Siefker-Radtke A, Zhang X, Guo CC, Shen Y, Pirollo KF, Sabir S, Leung C, Leong-Wu C, Ling C-M, Chang EH, Millikan RE, Benedict WF (2016) A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers. Mol Ther 24:1484\u20131491. https:\/\/doi.org\/10.1038\/mt.2016.118","journal-title":"Mol Ther"},{"key":"15_CR84","doi-asserted-by":"publisher","unstructured":"Silva AL, Moura LI, Carreira B, Conniot J, Matos AI, Peres C, Sainz V, Silva LC, Gaspar RS, Florindo HF (2018) Functional Moieties for Intracellular Traffic of Nanomaterials, in: Biomed. Appl. Funct. Nanomater., Elsevier, pp 399\u2013448. https:\/\/doi.org\/10.1016\/B978-0-323-50878-0.00014-8","DOI":"10.1016\/B978-0-323-50878-0.00014-8"},{"key":"15_CR85","doi-asserted-by":"publisher","unstructured":"Silva VL, Ferreira D, Nobrega FL, Martins IM, Kluskens LD, Rodrigues LR (2016) Selection of novel peptides homing the 4T1 cell line: Exploring alternative targets for triple negative breast cancer, PLoS One. 11. https:\/\/doi.org\/10.1371\/journal.pone.0161290.","DOI":"10.1371\/journal.pone.0161290"},{"key":"15_CR86","doi-asserted-by":"publisher","DOI":"10.1088\/1478-3975\/aadb68","volume":"15","author":"JD Smith","year":"2018","unstructured":"Smith JD, Cardwell LN, Porciani D, Nguyen JA, Zhang R, Gallazzi F, Tata RR, Burke DH, Daniels MA, Ulery BD (2018) Aptamer-displaying peptide amphiphile micelles as a cell-targeted delivery vehicle of peptide cargoes. Phys Biol 15:065006. https:\/\/doi.org\/10.1088\/1478-3975\/aadb68","journal-title":"Phys Biol"},{"key":"15_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144559","volume":"10","author":"BJ Solomon","year":"2015","unstructured":"Solomon BJ, Desai J, Rosenthal M, McArthur GA, Pattison ST, Pattison SL, MacDiarmid J, Brahmbhatt H, Scott AM (2015) A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted. Paclitaxel-Packaged Bacterial Minicells, PLoS One. 10:e0144559. https:\/\/doi.org\/10.1371\/journal.pone.0144559","journal-title":"Paclitaxel-Packaged Bacterial Minicells, PLoS One."},{"key":"15_CR88","doi-asserted-by":"publisher","unstructured":"Sousa D, Ferreira D, Rodrigues JL, Rodrigues LR (2019) Nanotechnology in Targeted Drug Delivery and Therapeutics. Appl. Target. Nano Drugs Deliv. Syst Elsevier, pp 357\u2013409. https:\/\/doi.org\/10.1016\/B978-0-12-814029-1.00014-4","DOI":"10.1016\/B978-0-12-814029-1.00014-4"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"1600260","DOI":"10.1002\/mabi.201600260","volume":"17","author":"C-W Su","year":"2017","unstructured":"Su C-W, Yen C-S, Chiang C-S, Hsu C-H, Chen S-Y (2017) Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo. Macromol Biosci 17:1600260. https:\/\/doi.org\/10.1002\/mabi.201600260","journal-title":"Macromol Biosci"},{"key":"15_CR90","doi-asserted-by":"publisher","unstructured":"Sunasee R, Narain R (2014) Covalent and Noncovalent Bioconjugation Strategies, in: Chem. Bioconjugates, John Wiley & Sons, Inc., Hoboken, NJ, USA, 2014: pp. 1\u201375. https:\/\/doi.org\/10.1002\/9781118775882.ch1.","DOI":"10.1002\/9781118775882.ch1"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s11671-016-1512-8","volume":"11","author":"J Tan","year":"2016","unstructured":"Tan J, Yang N, Hu Z, Su J, Zhong J, Yang Y, Yu Y, Zhu J, Xue D, Huang Y, Lai Z, Huang Y, Lu X, Zhao Y (2016) Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells. Nanoscale Res Lett 11:298. https:\/\/doi.org\/10.1186\/s11671-016-1512-8","journal-title":"Nanoscale Res Lett"},{"key":"15_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01161-y","author":"K Tsogtbaatar","year":"2021","unstructured":"Tsogtbaatar K, Sousa DA, Ferreira D, Tevlek A, Ayd\u0131n HM, \u00c7elik E, Rodrigues L (2021) In vitro selection of DNA aptamers against human osteosarcoma. Invest New Drugs. https:\/\/doi.org\/10.1007\/s10637-021-01161-y","journal-title":"Invest New Drugs"},{"key":"15_CR93","doi-asserted-by":"publisher","unstructured":"Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science (80). 249 (1990) 505\u2013510. https:\/\/doi.org\/10.1126\/science.2200121.","DOI":"10.1126\/science.2200121"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2745\/dds.19.439","volume":"19","author":"T Ura","year":"2004","unstructured":"Ura T, Shirao K, Matsumura Y, Hamaguchi T, Miyata Y, Okura H, Chin K, Yamao T, Kannami A, Takahashi K (2004) Clinical trial of MCC-465, a doxorubicin encapsulated in PEG-immunoliposome, in patients with metastatic stomach cancer. Drug Deliv. Syst. 19:439\u2013444. https:\/\/doi.org\/10.2745\/dds.19.439","journal-title":"Drug Deliv. Syst."},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1039\/C4BM00462K","volume":"3","author":"B Wu","year":"2015","unstructured":"Wu B, Yu P, Cui C, Wu M, Zhang Y, Liu L, Wang C-X, Zhuo R-X, Huang S-W (2015) Folate-containing reduction-sensitive lipid\u2013polymer hybrid nanoparticles for targeted delivery of doxorubicin. Biomater Sci 3:655\u2013664. https:\/\/doi.org\/10.1039\/C4BM00462K","journal-title":"Biomater Sci"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2018.1556359","volume":"26","author":"Y Xia","year":"2019","unstructured":"Xia Y, Zhong J, Zhao M, Tang Y, Han N, Hua L, Xu T, Wang C, Zhu B (2019) Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Deliv 26:1\u201311. https:\/\/doi.org\/10.1080\/10717544.2018.1556359","journal-title":"Drug Deliv"},{"key":"15_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.112366","volume":"212","author":"D Xiao","year":"2022","unstructured":"Xiao D, Huang Y, Huang S, Zhuang J, Chen P, Wang Y, Zhang L (2022) Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer. Colloids Surfaces B Biointerfaces. 212:112366. https:\/\/doi.org\/10.1016\/j.colsurfb.2022.112366","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"15_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121489","volume":"284","author":"Y Xu","year":"2022","unstructured":"Xu Y, Ma S, Zhao J, Chen H, Si X, Huang Z, Yu Z, Song W, Tang Z, Chen X (2022) Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity. Biomaterials 284:121489. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121489","journal-title":"Biomaterials"},{"key":"15_CR99","doi-asserted-by":"publisher","unstructured":"Xu L, Faruqu FN, Lim YM, Lim KY, Liam-Or R, Walters AA, Lavender P, Fear D, Wells CM, Wang JT, Al-Jamal KT (2021) Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment, Biomaterials. 264 (2021) 120369. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120369","DOI":"10.1016\/j.biomaterials.2020.120369"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/cancers11050640","volume":"11","author":"J Yoo","year":"2019","unstructured":"Yoo J, Park C, Yi G, Lee D, Koo H (2019) Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers (basel). 11:640. https:\/\/doi.org\/10.3390\/cancers11050640","journal-title":"Cancers (basel)."},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.biomaterials.2009.11.047","volume":"31","author":"D-H Yu","year":"2010","unstructured":"Yu D-H, Lu Q, Xie J, Fang C, Chen H-Z (2010) Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials 31:2278\u20132292. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.11.047","journal-title":"Biomaterials"},{"key":"15_CR102","doi-asserted-by":"publisher","unstructured":"Yu MK, Park J, S. Jon (2012) Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy, Theranostics. 2. https:\/\/doi.org\/10.7150\/thno.3463","DOI":"10.7150\/thno.3463"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"22015","DOI":"10.1038\/s41598-020-79125-0","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Zhang F, Han M, Wang X, Du J, Zhang H, Li W (2020) Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer. Sci Rep 10:22015. https:\/\/doi.org\/10.1038\/s41598-020-79125-0","journal-title":"Sci Rep"},{"key":"15_CR104","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Ukidve A, Kim J, Mitragotri S (2020) Targeting Strategies for Tissue-Specific Drug Delivery. Cell 181:151\u2013167. https:\/\/doi.org\/10.1016\/j.cell.2020.02.001","journal-title":"Cell"},{"key":"15_CR105","doi-asserted-by":"publisher","unstructured":"Zhao B, Chen S, Hong Y, Jia L, Zhou Y, He X, Wang Y, Tian Z, Yang Z, Gao D (2022) Research Progress of Conjugated Nanomedicine for Cancer Treatment., Pharmaceutics. 14 (2022). https:\/\/doi.org\/10.3390\/pharmaceutics14071522","DOI":"10.3390\/pharmaceutics14071522"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejps.2017.10.036","volume":"111","author":"G Zheng","year":"2018","unstructured":"Zheng G, Zhao R, Xu A, Shen Z, Chen X, Shao J (2018) Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy. Eur J Pharm Sci 111:492\u2013502. https:\/\/doi.org\/10.1016\/j.ejps.2017.10.036","journal-title":"Eur J Pharm Sci"},{"key":"15_CR107","doi-asserted-by":"publisher","unstructured":"Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis ME, Yen Y (2014) Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci 111:11449\u201311454. https:\/\/doi.org\/10.1073\/pnas.1411393111","DOI":"10.1073\/pnas.1411393111"}],"container-title":["Environmental Science and Engineering","Biogenic Nanomaterials for Environmental Sustainability: Principles, Practices, and Opportunities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-45956-6_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:28:10Z","timestamp":1757096890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-45956-6_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031459559","9783031459566"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-45956-6_15","relation":{},"ISSN":["1863-5520","1863-5539"],"issn-type":[{"type":"print","value":"1863-5520"},{"type":"electronic","value":"1863-5539"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"4 January 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}